Modification at the C9 position of the marine natural product isoaaptamine and the impact on HIV-1, mycobacterial, and tumor cell activity
A series of isoaaptamine analogs were prepared at the C9 position of isoaaptamine ( 2) and were evaluated for their biological activity against HIV-1, Mtb, AIDS-OI, tropical parasitic diseases, and cancer. As part of an investigation to generate optimized drug leads from marine natural pharmacophore...
Saved in:
Published in | Bioorganic & medicinal chemistry Vol. 14; no. 24; pp. 8495 - 8505 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Elsevier Ltd
15.12.2006
Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A series of isoaaptamine analogs were prepared at the C9 position of isoaaptamine (
2) and were evaluated for their biological activity against HIV-1, Mtb, AIDS-OI, tropical parasitic diseases, and cancer.
As part of an investigation to generate optimized drug leads from marine natural pharmacophores for the treatment of neoplastic and infectious diseases, a series of novel isoaaptamine analogs were prepared by coupling acyl halides to the C9 position of isoaaptamine (
2) isolated from the
Aaptos sponge. This library of new semisynthetic products was evaluated for biological activity against HIV-1, Mtb, AIDS-OI, tropical parasitic diseases, and cancer. Compound
4 showed potent activity against HIV-1 (EC
50 0.47
μg/mL), compound
19 proved to possess remarkable activity against
Mycobacterium intracellulare with an IC
50 and MIC value of 0.15 and 0.31
μg/mL, while compounds
4 and
17 possessed anti-leishmanial activity with IC
50 values of 0.1 and 0.4
μg/mL, respectively. Compounds
16 and
17 showed antimalarial activity with EC
50 values of 230 and 240
ng/mL, respectively, and compound
14 exhibited an EC
50 of 0.05
μM against the Leukemia cell line K-562. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2006.08.042 |